Arkolith/Insider Trading/VYGR/Form 4

Carter Todd Alfred

Chief Scientific OfficerVoyager Therapeutics, Inc. (VYGR) · full profile →Form 4 · filed Sep 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$86K
Net Open-Market Flow
-$86K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2023Sell(S)11K$8.16$86K54K
Sep 15, 2023Option exercise(M)5K$2.85$14K65K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 15, 2023Option exercise(M)5K—$040K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-101631) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML